Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
GCM Grosvenor
GCMG
$2.81B
| $3.66M | 0.01% |
408,700
+22,500
| +6% | +$187K |
|
1552
Cooper-Standard Automotive
CPS
$506M
| $3.65M | 0.01% |
187,000
-84,500
| -31% | -$1.35M |
|
1553
National Health Investors
NHI
$3.58B
| $3.65M | 0.01% |
65,300
+4,400
| +7% | +$233K |
|
|
BLUE
1554
DELISTED
bluebird bio
BLUE
| $3.64M | 0.01% |
131,935
+108,190
| +456% | +$6.6M |
|
|
TPC
1555
Tutor Perini Cor
TPC
$5.09B
| $3.64M | 0.01% |
399,880
-5,500
| -1% | -$43.8K |
|
|
JAMF
1556
DELISTED
Jamf
JAMF
| $3.6M | 0.01% |
199,184
-2,616
| -1% | -$44.2K |
|
1557
Pagaya Technologies
PGY
$1.8B
| $3.6M | 0.01% |
+217,067
| New | +$3.54M |
|
1558
iShares Europe ETF
IEV
$1.7B
| $3.59M | 0.01% |
68,000
+62,100
| +1,053% | +$3.06M |
|
1559
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $3.59M | 0.01% |
95,200
+57,300
| +151% | +$2.05M |
|
1560
Invesco S&P 500 GARP ETF
SPGP
$2.33B
| $3.58M | 0.01% |
+36,500
| New | +$3.37M |
|
1561
Portland General Electric
POR
$5.97B
| $3.57M | 0.01% |
+82,372
| New | +$3.42M |
|
1562
Bakkt Inc
BKKT
$342M
| $3.57M | 0.01% |
63,988
+26,460
| +71% | +$916K |
|
1563
Relay Therapeutics
RLAY
$4.35B
| $3.56M | 0.01% |
323,700
+179,000
| +124% | +$1.51M |
|
1564
Adtran
ADTN
$684M
| $3.56M | 0.01% |
485,373
-173,300
| -26% | -$1.14M |
|
|
BCOV
1565
DELISTED
Brightcove, Inc.
BCOV
| $3.55M | 0.01% |
1,371,797
+177,409
| +15% | +$476K |
|
1566
iShares Silver Trust
SLV
$31.5B
| $3.55M | 0.01% |
+163,000
| New | +$3.47M |
|
1567
ProShares Ultra Dow30
DDM
$542M
| $3.55M | 0.01% |
+89,600
| New | +$3.08M |
|
1568
John Wiley & Sons Class A
WLY
$2.61B
| $3.55M | 0.01% |
+111,800
| New | +$3.5M |
|
1569
InfuSystem Holdings
INFU
$244M
| $3.54M | 0.01% |
336,309
-10,600
| -3% | -$104K |
|
1570
Telus
TU
$15.4B
| $3.52M | 0.01% |
197,566
-76,334
| -28% | -$1.32M |
|
1571
The Joint Corp
JYNT
$120M
| $3.52M | 0.01% |
366,647
+72,080
| +24% | +$625K |
|
1572
Amplitude
AMPL
$1.63B
| $3.52M | 0.01% |
276,400
+47,600
| +21% | +$528K |
|
1573
Organogenesis Holdings
ORGO
$230M
| $3.51M | 0.01% |
857,725
+173,631
| +25% | +$486K |
|
1574
Zurn Elkay Water Solutions
ZWS
$8.45B
| $3.5M | 0.01% |
119,103
-169,590
| -59% | -$4.8M |
|
1575
Gorman-Rupp
GRC
$2.13B
| $3.5M | 0.01% |
98,500
-3,300
| -3% | -$106K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.